Aytu Biopharma (AYTU) Cash from Operations (2010 - 2026)
Aytu Biopharma (AYTU) posted Cash from Operations of $4.41 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 57.2% from $2.8 million a year earlier.
Powered by 
Analysis
Aytu Biopharma (AYTU) Cash from Operations (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma's Cash from Operations came in at $3.28 million.
- In prior fiscal years, Aytu Biopharma's Cash from Operations was -$1.94 million in FY2025, -$1.39 million in FY2024, -$5.13 million in FY2023 and -$28.82 million in FY2022.
- The fiscal Q4 2026 figure stands as the highest quarterly Cash from Operations since fiscal Q4 2023.
- According to Business Quant data, Cash from Operations for the three prior fiscal quarters was -$4.18 million (Q3 2026), $3.68 million (Q2 2026) and -$618,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn | 4.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.41 Mn |
| Mar 31, 2026 | -4.18 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | -618,000.00 |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | -6.46 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Jun 30, 2024 | -788,000.00 |
| Mar 31, 2024 | -254,000.00 |
| Dec 31, 2023 | -135,000.00 |
| Sep 30, 2023 | -211,000.00 |
| Jun 30, 2023 | 9.37 Mn |
| Mar 31, 2023 | -2.90 Mn |
| Dec 31, 2022 | -2.45 Mn |
| Sep 30, 2022 | -9.15 Mn |
| Jun 30, 2022 | -7.10 Mn |
| Mar 31, 2022 | -9.12 Mn |
| Dec 31, 2021 | -8.81 Mn |
| Sep 30, 2021 | -3.80 Mn |
API Access
Aytu Biopharma Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();